NCT06775613View on ClinicalTrials.gov

Solving Challenging Diagnoses Through Ultra-long Read Sequencing

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

March 20, 2024

Study Completion Date

December 31, 2025

Conditions
Variant Nucleotide
Interventions
GENETIC

Long-read sequencing

The technology performed belongs to third-generation sequencing strategies and is capable of analysing very long DNA and RNA fragments.

Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER